The c-Abl tyrosine kinase controls protein kinase Cδ-induced Fli-1 phosphorylation in human dermal fibroblasts

Arthritis and Rheumatism

Volumn 63, Issue 6, 2011, Pages 1729-1737

  Bujor, Andreea M ^a   Asano, Yoshihide ^b   Haines, Paul ^a   Lafyatis, Robert ^a   Trojanowska, Maria ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; BETA ACTIN; COLLAGEN TYPE 1; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EARLY GROWTH RESPONSE FACTOR 1; IMATINIB; LAMIN A; LAMIN C; MESSENGER RNA; PROTEIN KINASE C DELTA; SMALL INTERFERING RNA; THREONINE; TRANSCRIPTION FACTOR FLI 1; TRANSFORMING GROWTH FACTOR BETA;

ACETYLATION; ADENOVIRUS; ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; NUCLEAR LOCALIZATION SIGNAL; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; UPREGULATION; WESTERN BLOTTING;

CELL NUCLEUS; CELLS, CULTURED; COLLAGEN TYPE I; DERMIS; FEMALE; FIBROBLASTS; HUMANS; MALE; MICROFILAMENT PROTEINS; PHOSPHORYLATION; PIPERAZINES; PROTEIN KINASE C-DELTA; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA, SMALL INTERFERING; SCLERODERMA, SYSTEMIC; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 79958056369     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30284     Document Type: Article

References (33)

1. Trojanowska M,. Noncanonical transforming growth factor β signaling in scleroderma fibrosis. Curr Opin Rheumatol 2009; 21: 623-9.
2. Steinberg SF,. Distinctive activation mechanisms and functions for protein kinase Cδ. Biochem J 2004; 384: 449-59. (Pubitemid 40018958)
3. Kikkawa U, Matsuzaki H, Yamamoto T,. Protein kinase Cδ (PKCδ): activation mechanisms and functions. J Biochem 2002; 132: 831-9. (Pubitemid 36090647)
4. Jimenez SA, Gaidarova S, Saitta B, Sandorfi N, Herrich DJ, Rosenbloom JC, et al. Role of protein kinase C-δ in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 2001; 108: 1395-403. (Pubitemid 33107768)
5. Jinnin M, Ihn H, Yamane K, Mimura Y, Asano Y, Tamaki K,. Alpha2(I) collagen gene regulation by protein kinase C signaling in human dermal fibroblasts. Nucleic Acids Res 2005; 33: 1337-51. (Pubitemid 41439927)
6. Hart A, Melet F, Grossfeld P, Chien K, Jones C, Tunnacliffe A, et al. Fli-1 is required for murine vascular and megakaryocytic development and is hemizygously deleted in patients with thrombocytopenia. Immunity 2000; 13: 167-77.
7. Asano Y, Stawski L, Hant F, Highland K, Silver R, Szalai G, et al. Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy. Am J Pathol 2010; 176: 1983-98.
8. Czuwara-Ladykowska J, Shirasaki F, Jackers P, Watson DK, Trojanowska M,. Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway. J Biol Chem 2001; 276: 20839-48.
9. Nakerakanti SS, Kapanadze B, Yamasaki M, Markiewicz M, Trojanowska M,. Fli1 and Ets1 have distinct roles in connective tissue growth factor/CCN2 gene regulation and induction of the profibrotic gene program. J Biol Chem 2006; 281: 25259-69. (Pubitemid 44401913)
10. Jinnin M, Ihn H, Mimura Y, Asano Y, Yamane K, Tamaki K,. Matrix metalloproteinase-1 up-regulation by hepatocyte growth factor in human dermal fibroblasts via ERK signaling pathway involves Ets1 and Fli1. Nucleic Acids Res 2005; 33: 3540-9. (Pubitemid 41430577)
11. Shirasaki F, Makhluf HA, LeRoy C, Watson DK, Trojanowska M,. Ets transcription factors cooperate with Sp1 to activate the human tenascin-C promoter. Oncogene 1999; 18: 7755-64. (Pubitemid 30052760)
12. Kubo M, Czuwara-Ladykowska J, Moussa O, Markiewicz M, Smith E, Silver RM, et al. Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin. Am J Pathol 2003; 163: 571-81. (Pubitemid 36909419)
13. Asano Y, Trojanowska, M,. Phosphorylation of Fli1 at threonine 312 by protein kinase Cδ promotes its interaction with p300/CREB-binding protein-associated factor and subsequent acetylation in response to transforming growth factor β. Mol Cell Biol 2009; 29: 1882-94.
14. Bujor AM, Nakerakanti S, Morris E, Hant FN, Trojanowska M,. Akt inhibition up-regulates MMP1 through a CCN2-dependent pathway in human dermal fibroblasts. Exp Dermatol 2010; 19: 347-54.
15. Bujor AM, Pannu J, Bu S, Smith EA, Muise-Helmericks RC, Trojanowska M,. Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts. J Invest Dermatol 2008; 128: 1906-14. (Pubitemid 352001221)
16. Heidkamp MC, Bayer AL, Martin JL, Samarel AM,. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase Cε and δ in neonatal rat ventricular myocytes. Circ Res 2001; 89: 882-90. (Pubitemid 34627893)
17. Wang Y, Fan PS, Kahaleh B,. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum 2006; 54: 2271-9. (Pubitemid 44051084)
18. Asano Y, Czuwara J, Trojanowska M,. Transforming growth factor-β regulates DNA binding activity of transcription factor Fli1 by p300/CREB-binding protein-associated factor-dependent acetylation. J Biol Chem 2007; 282: 34672-83. (Pubitemid 350232412)
19. Elkareh J, Periyasamy SM, Shidyak A, Vetteth S, Schroeder J, Raju V, et al. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 2009; 296: F1219-26.
20. Sakthianandeswaren A, Curtis JM, Elso C, Kumar B, Baldwin TM, Lopaticki S, et al. Fine mapping of Leishmania major susceptibility Locus lmr2 and evidence of a role for Fli1 in disease and wound healing. Infect Immun 2010; 78: 2734-44.
21. Shaul Y,. c-Abl: activation and nuclear targets. Cell Death Differ 2000; 7: 10-6. (Pubitemid 30153759)
22. Borthakur G, Cortes JE,. Imatinib mesylate in the treatment of chronic myelogenous leukemia. Int J Hematol 2004; 79: 411-9. (Pubitemid 38808356)
23. Pannu J, Asano Y, Nakerakanti S, Smith E, Jablonska S, Blaszczyk M, et al. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum 2008; 58: 2528-37.
24. Bhattacharyya S, Ishida W, Wu M, Wilkes M, Mori Y, Hinchcliff M, et al. A non-Smad mechanism of fibroblast activation by transforming growth factor-β via c-Abl and Egr-1: selective modulation by imatinib mesylate. Oncogene 2009; 28: 1285-97.
25. Van Daele PL, Dik WA, Thio HB, van Hal PT, van Laar JA, Hooijkaas H, et al. Is imatinib mesylate a promising drug in systemic sclerosis? Arthritis Rheum 2008; 58: 2549-52.
26. Sfikakis PP, Gorgoulis VG, Katsiari CG, Evangelou K, Kostopoulos C, Black CM,. Imatinib for the treatment of refractory, diffuse systemic sclerosis. Rheumatology (Oxford) 2008; 47: 735-7. (Pubitemid 351619226)
27. Chung L, Fiorentino DF, BenBarak MJ, Adler AS, Mariano MM, Paniagua RT, et al. Molecular framework for response to imatinib mesylate in systemic sclerosis. Arthritis Rheum 2009; 60: 584-91.
28. Gordon J, Spiera R,. Imatinib and the treatment of fibrosis: recent trials and tribulations. Curr Rheumatol Rep 2011; 13: 51-8.
29. Yuan ZM, Utsugisawa T, Ishiko T, Nakada S, Huang Y, Kharbanda S, et al. Activation of protein kinase Cδ by the c-Abl tyrosine kinase in response to ionizing radiation. Oncogene 1998; 16: 1643-8. (Pubitemid 28175044)
30. Sun X, Wu F, Datta R, Kharbanda S, Kufe D,. Interaction between protein kinase Cδ and the c-Abl tyrosine kinase in the cellular response to oxidative stress. J Biol Chem 2000; 275: 7470-3. (Pubitemid 30159641)
31. Jackson DN, Foster DA,. The enigmatic protein kinase Cδ: complex roles in cell proliferation and survival. FASEB J 2004; 18: 627-36. (Pubitemid 38451785)
32. Lu W, Finnis S, Xiang C, Lee HK, Markowitz Y, Okhrimenko H, et al. Tyrosine 311 is phosphorylated by c-Abl and promotes the apoptotic effect of PKCδ in glioma cells. Biochem Biophys Res Commun 2007; 352: 431-6. (Pubitemid 44838505)
33. Zijlstra F,. A novel δ-protein-kinase inhibitor for adjunctive therapy during percutaneous coronary intervention. Nat Clin Pract Cardiovasc Med 2008; 5: 446-7.